Back to Search
LYDIA USHA, M.D.
M.D.
Medical Oncology Physician
NPI: 1336109693IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
036-096422(IL)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1982
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (3)
Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts.
PMID 18702822·J Hematol Oncol·2008
8-other
CD5+ immunophenotype in the bone marrow but not in the peripheral blood in a patient with hairy cell leukemia.
PMID 11014896·Acta Haematol·2000
5-case
Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer.
PMID 17243161·Genes Chromosomes Cancer·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1725 W HARRISON ST, SUITE 1010
CHICAGO, IL 60612 - Phone
- (312) 942-5904
Quick Facts
- NPI
- 1336109693
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 44
- Clinical Trials
- 1
- Publications
- 3
Are you this provider?
Claim Your Profile